fa wise on aria , guessing that the p1 trial news was not overwhelming(as i thought it might be)..still this is a totally new target approach..and they were smart to try multiple canvcer types...some tweaking may be needed..so time will tell..and they , aria, pushing back a stent deal was a letdown..so a takedown was inevitable, i didnt think it would be so brutal though....im out of aria now, see my last to zeev on it, took a giant beating that really hurt....i will get back in it though at some point.
i also added dndn yesterday at same area..yes im concerned.. ..they support each bio then whack it when you least suspect it....both good and bad, dndn could get hint of provenge approval or release more p3 news at any time..
cris is cheap here, i added yest and also ingn..of course they could get cheaper.....
Market Data 
Markets 
AI
